Bart Neyns
巴特·内恩斯
MD, PhD
Head, Department of Medical Oncology; Professor of Medical Oncology肿瘤内科系主任；肿瘤内科学教授
👥Biography 个人简介
Bart Neyns at UZ Brussel is Belgium's leading melanoma oncologist and a key European contributor to ipilimumab and nivolumab pivotal trials. He has championed access to immunotherapy for Belgian patients and led studies on melanoma brain metastases, establishing immunotherapy as effective in this historically poor-prognosis setting.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
European Melanoma Immunotherapy Trials
Principal investigator for ipilimumab and nivolumab pivotal trials at UZ Brussel, contributing to European regulatory approvals and establishing local immunotherapy infrastructure for advanced melanoma.
Melanoma Brain Metastases
Led and contributed to CheckMate 204 and ABC trials demonstrating clinically meaningful intracranial responses with nivolumab+ipilimumab in melanoma patients with brain metastases.
Representative Works 代表性著作
Ipilimumab in Patients with Melanoma and Brain Metastases: An Open-Label, Phase 2 Trial
The Lancet Oncology (2012)
Demonstrated activity of ipilimumab in melanoma brain metastases, opening checkpoint blockade for a population with extremely poor prognosis.
Nivolumab plus Ipilimumab in Melanoma Metastatic to the Brain (CheckMate 204)
New England Journal of Medicine (2019)
Established dual checkpoint blockade as effective and durable in active brain metastases, redefining treatment options for this high-risk subgroup.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 巴特·内恩斯 的研究动态
Follow Bart Neyns's research updates
留下邮箱，当我们发布与 Bart Neyns（UZ Brussel (Universitair Ziekenhuis Brussel), Vrije Universiteit Brussel）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment